News

Biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) ended 2023 with an important regulatory approval. The company's gene-editing therapy for a duo of blood-related disorders, Casgevy, earned the nod

Image source: The Motley Fool.

Vertex Pharmaceuticals (NASDAQ: VRTX)Q4 2023 Earnings CallFeb 05, 2024, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Still basking in the afterglow of an encouraging quarterly earnings report, AbbVie (NYSE: ABBV) stock saw a healthy 1.5% rise in price across Monday's trading session. What helped was a series of

Shares of Catalent (NYSE: CTLT) rose by 9.7% on Monday after the pharmaceutical contract manufacturing and drug delivery technology specialist agreed to be acquired by Novo Holdings, the parent

A major acquisition by its controlling shareholder pushed Novo Nordisk's (NYSE: NVO) U.S.-listed shares 4% higher on Monday. As a result of the deal, Novo Nordisk will acquire from that shareholder

One of the more important qualities an investor can have is patience. The stock market is volatile, and even great companies see their stock prices go through down periods. What's important, though

When is it time to buy a stock? One of the best-known pieces of investing advice tells us to buy low and sell high. But what constitutes "low" is relative. A stock near its 52-week high can still be

With the stock market recently hitting new all-time highs again, times are exciting for people who are fully invested, but these conditions can be more frustrating for those who have cash available

Dividend Kings are unquestionably among the top picks for income-seeking investors. These are companies that have increased their payouts for at least 50 consecutive years, which strongly suggests

UnitedHealth Group (NYSE: UNH) is one of the largest healthcare companies in the world. Its market cap sits at around $470 billion. And this is a stock that has risen tremendously in value. In the

Shares of telecom giant AT&T (NYSE: T) have been stuck in a downtrend since the start of the pandemic in 2020. From peak to trough, the stock was down more than 50% at one point during 2023.

The

Any time is a good time to buy solid dividend stocks. But this month is a special time to do so for one simple reason: There's an extra day for investors to buy stocks because it's a leap year.

A recent survey conducted by the Nationwide Retirement Institute revealed that retirees view inflation and potential Social Security benefit cuts as their biggest concerns. And the Harvard

Medical device maker Medtronic (NYSE: MDT) offers investors a couple of ways to build wealth: through the stock's gains and through its dividend income. Over the past decade, the stock has risen by

Nvidia (NASDAQ: NVDA) won over Wall Street last year, illustrated by its more than 210% stock growth since January 2023.

The company's years of dominance in graphics processing units (GPUs)

Abbott Laboratories (NYSE: ABT) is a diversified health care company that gives investors a great deal of stability. Between testing, nutritional products, pharmaceuticals, and medical devices, the

Everybody loves a good recovery story. You can get in on a promising company, with a potentially bright future ahead, but at a terrific price. And that means you could win big each time this player

Vertex Pharmaceuticals (NASDAQ: VRTX) already brings in billions of dollars annually, thanks to its cystic fibrosis (CF) drugs. The company recently proved it could expand beyond the specialty area

Image source: The Motley Fool.

AbbVie (NYSE: ABBV)Q4 2023 Earnings CallFeb 02, 2024, 9:00 a.m. ET

Operator

Continue reading

Source Fool.com

Image source: The Motley Fool.

Cigna Group (NYSE: CI)Q4 2023 Earnings CallFeb 02, 2024, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Plug Power (NASDAQ: PLUG) stock absolutely crushed the market this week, surging a massive 42% at its highest point in trading through noon ET Friday, according to data provided by S&P Global Market

Drugmakers Novo Nordisk and Eli Lilly have been making headlines in recent times, thanks to their sought-after weight loss drugs. In fact, the products have become so popular that demand has

Veteran healthcare company Merck (NYSE: MRK) was looking very healthy on the stock market Thursday. Its shares gained 4.6% in value across the day, following the publication of quarterly results